Related Experiment Videos
[Intraventricular therapy in the management of ventricular ependymitis]
Insights
Intraventricular amynoglucoside antibiotics show promise for treating purulent meningitis and ventricular ependymitis in children. This treatment approach resulted in no deaths in children without central nervous system malformations.
Area of Science:
- Pediatric Infectious Diseases
- Neuroscience
- Pharmacology
Context:
- Ventricular ependymitis is a serious infection of the brain's ventricles.
- Gram-negative bacterial meningitis poses a significant threat to children.
- Intraventricular antibiotic delivery offers a direct route to treat CNS infections.
Purpose:
- To evaluate the efficacy of intraventricular amynoglucoside antibiotics in children with purulent meningitis and ventricular ependymitis.
- To compare treatment outcomes in children with and without central nervous system (CNS) malformations.
Summary:
- Ten children with purulent meningitis and ventricular ependymitis (without CNS malformations) received three weeks of intraventricular amynoglucoside antibiotics via Scott's tubes, with no deaths.
- Sixteen children with ventricular ependymitis and CNS malformations also received treatment; four experienced therapeutic failures linked to encephalodysplasia or intraventricular shunts.
- The study highlights encouraging results, suggesting a potential reduction in mortality rates for ventricular ependymitis.
Impact:
- Demonstrates a potentially life-saving treatment for severe pediatric CNS infections.
- Provides evidence for tailored treatment approaches based on the presence of CNS malformations.
- Suggests amynoglucoside antibiotics administered intraventricularly are effective in combating gram-negative bacterial meningitis and ependymitis.
Abstract:
Through Scott's tubes, intraventricular administration of amynoglucoside antibiotics was given to two groups of patients: a) ten children with purulent meningitis and ventricular ependymitis due to gram - negative germs without malformation of the central nervous system (CNS) and b) sixteen children with ventricular ependymitis and malformation of the CNS. The duration of treatment was three weeks and no deaths issued in the first group. In the second group, there were four therapeutic failures related with the existence of encephalodysplasia or intraventricular wailing. The results described are very encouraging and allow to foresee a marked drop in the lethality of ventricular ependymitis.